Cutaneous Oncology News

Germline mutations in the BAP1 gene may be associated with melanocytic BAP1–mutated atypical intradermal tumors, according to recent findings.

Voriconazole was associated with a statistically significant increase in cutaneous squamous cell carcinoma risk in a cohort of individuals who underwent hematopoietic cell transplantation.

Common Terminology Criteria for Adverse Events may not appropriately reflect immune-related adverse event severity, duration or timing, according to study results.

The FDA granted priority review to brentuximab vedotin for the treatment of cutaneous T-cell lymphoma, according to the drug’s manufacturer.

There was no increased risk for subsequent squamous cell carcinoma associated with Erivedge treatment compared with standard treatment for patients with basal cell carcinoma, according to recently published study results in the Journal of the American Academy of Dermatology.

Patients with perineural invasion in cutaneous squamous cell carcinoma were more likely to experience recurrence than patients without perineural invasion, according to findings from a systematic review.

Patients with Merkel cell carcinoma experienced satisfactory overall survival results following an adjuvant radiation therapy dose ranging from 40 Gy to lower than 50 Gy.

Patients had a positive reaction to having a primary care physician conduct a clinical skin examination, according to recently published study results in JAMA Dermatology.

Study results reporting that nail findings distinguished patients with psoriatic arthritis from those with psoriasis without arthritis was among the top read articles in July on Healio.com/Dermatology.

Phosphodiesterase type 5 inhibitors were associated with a moderate increase in risk for melanoma and basal cell carcinoma, but not squamous cell carcinoma, according to recent findings.